Pfizer and BioNTech have started testing an Omicron-specific COVID-19 vaccine for adults
The study will measure the safety and effectiveness of a vaccine specifically tailored to the Omicron variant in adults ages 18 to 55.
Full Article
Pfizer and BioNTech have started testing an Omicron-specific COVID-19 vaccine for adults
Business Insider
0 shares
1 views
You might like
Related news coverage
Pfizer Says Updated COVID-19 Shot Effective Against Omicron
Wibbitz Top Stories
Pfizer Says Updated COVID-19 Shot , Effective Against Omicron.
NBC News reports Pfizer announced on
June 25 that its..
FDA Panel Endorses COVID Vaccines for Children Under 5
Wibbitz Top Stories
Advertisement
More coverage
EU Regulator Recommends Authorization Of Pfizer COVID Antiviral Pill
Newsy
Watch VideoThe European Medicines Agency has recommended that Pfizer's coronavirus antiviral drug be authorized for use in the..
-
Moderna announces full US approval for its COVID-19 vaccine
SeattlePI.com
-
Why Novavax Stock Is Sinking Again This Week
Motley Fool
-
Moderna begins testing omicron-matched COVID shots in adults
SeattlePI.com
-
Pfizer, BioNTech testing omicron vaccine, 39 missing after boat capsizes: 5 Things podcast
USATODAY.com